scholarly article | Q13442814 |
P356 | DOI | 10.3346/JKMS.2007.22.S.S52 |
P8608 | Fatcat ID | release_jk2qsifecrbrde7ghjom2inyny |
P932 | PMC publication ID | 2694387 |
P698 | PubMed publication ID | 17923756 |
P5875 | ResearchGate publication ID | 5920806 |
P50 | author | Yeul Hong Kim | Q98617374 |
P2093 | author name string | Hyun Jin Kim | |
Eun Jung Choi | |||
Seok Jin Kim | |||
Young Mi Whang | |||
P2860 | cites work | Therapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant sub-line. | Q53682893 |
Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide | Q60997520 | ||
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck | Q68537067 | ||
Phase II trial of all-trans retinoic acid in metastatic non-small cell lung cancer | Q71556856 | ||
N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium | Q74216044 | ||
Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells | Q74530097 | ||
9-cis retinoic acid is a high affinity ligand for the retinoid X receptor | Q28119031 | ||
Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines | Q28372007 | ||
The RXR heterodimers and orphan receptors | Q29547867 | ||
Cellular response to oxidative stress: signaling for suicide and survival | Q34138566 | ||
N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells | Q34594976 | ||
Retinoids--"differentiation agents" for cancer treatment and prevention | Q35237425 | ||
13-cis-retinoic acid and cancer chemoprevention | Q35356441 | ||
Molecularly targeted approaches to the chemoprevention of lung cancer | Q35817534 | ||
Retinoids and their receptors in differentiation, embryogenesis, and neoplasia | Q36448344 | ||
Retinoids as modulators of tumor cells invasion and metastasis | Q37363118 | ||
Studies of synergistic and antagonistic combinations of conventional cytotoxic agents with the multiple eicosanoid pathway modulator LY 293111. | Q40509177 | ||
Retinoids and cancer: a basis for differentiation therapy | Q40860954 | ||
Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. | Q40951916 | ||
Secretion of N-(4-hydroxyphenyl) retinamide-retinol-binding protein from liver parenchymal cells: evidence for reduced affinity of the complex for transthyretin | Q41109859 | ||
Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression | Q41229162 | ||
9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2. | Q42167563 | ||
Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. | Q42280130 | ||
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer | Q43579847 | ||
Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells | Q43786672 | ||
Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy? | Q44068904 | ||
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial | Q44303836 | ||
N-(4-hydroxyphenyl)-retinamide selectively increases All-TRANS retinoic acid inhibitory effects in HER2/NEU-overexpressing breast cancer cells | Q44321643 | ||
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. | Q44471521 | ||
Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites. | Q44615083 | ||
4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors | Q46690362 | ||
Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines | Q48024992 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tretinoin | Q29417 |
lung carcinoma | Q18556110 | ||
P304 | page(s) | S52-60 | |
P577 | publication date | 2007-09-01 | |
P1433 | published in | Journal of Korean Medical Science | Q24039955 |
P1476 | title | Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro | |
P478 | volume | 22 Suppl |
Q43193914 | All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism. |
Q39583349 | Characterization and functional analysis of the human microRNA let-7a2 promoter in lung cancer A549 cell lines |
Q45534828 | Preparation and in vitro characterization of retinoic acid-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) micelles |
Q89510543 | Retinoic Acids in the Treatment of Most Lethal Solid Cancers |
Q41573464 | Synergistic effect of fenretinide and curcumin for treatment of non-small cell lung cancer. |
Q93121747 | The potential of retinoids for combination therapy of lung cancer: Updates and future directions |
Q28261714 | The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer |
Search more.